Research Directory

Rare Diseases AbbVie-Shire merger could be a new beginning

Read more

What next for the EMA's transparency policy?

Read more

Stocks mostly stable amid the fireworks

Read more

How outcomes measures can improve healthcare

Read more

All roads lead to health technology assessment

Read more

Commentary: Big deals for Big Pharma

Read more

European biotechs rise in March quarter

Read more

Checkpoint inhibitors - A new horizon for cancer therapy

Read more

The EU Clinical Trials Regulation: Legislators see light at the end of the tunnel

Read more

Banner year for biotechs

Read more